Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review

by Stephen McGeorge, Michael Kwok, Andrew Jiang, Louise Emmett, David A. Pattison, Paul A. Thomas, John W. Yaxley, Matthew J. Roberts
Published 2021-01-01

External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage...

by Henk B. Luiting, Sebastiaan Remmers, Dennie Meijer, André N. Vis, Maarten Donswijk, Daniela E. Oprea-Lager, Louise Emmett, Isabel Rauscher, Henk G. Van der Poel, Monique J. Roobol, Pim J. van Leeuwen
Published 2021-06-01

Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging

by Wei Liu, MD, Katherine Zukotynski, MD, PhD, FRCPC, Louise Emmett, MD, FRACP, Hans T. Chung, MD, FRCPC, Peter Chung, MD, FRCPC, Robert Wolfson, MD, FRCPC, Irina Rachinsky, MD, MSc, FRCPC, Anil Kapoor, MD, FRCSC, Ur Metser, MD, FRCPC, Andrew Loblaw, MD, MSc, FRCPC, Gerard Morton, MB, FRCPC, Tracy Sexton, MD, PhD, FRCPC, Michael Lock, MD, FRCPC, Joelle Helou, MD, MSc, Alejandro Berlin, MD, MSc, Colm Boylan, MB, FRCPC, Susan Archer, BSc, Gregory R. Pond, PhD, PStat, Glenn Bauman, MD, FRCPC
Published 2021-01-01